characteristics.text: SAMN46022372
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-12-30T12:52:21.267Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-08-31T13:32:35.953Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS23798360
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS23798360
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_CALGB_40603
characteristics.characteristic: biospecimen repository
characteristics.text: Sample_NORMAL_287
characteristics.characteristic: biospecimen repository sample id
characteristics.text: blood
characteristics.characteristic: body site
characteristics.text: phs003801
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: DS-CA-COL
characteristics.characteristic: gap_consent_short_name
characteristics.text: 5760502
characteristics.characteristic: gap_sample_id
characteristics.text: 3025420
characteristics.characteristic: gap_subject_id
characteristics.text: blood
characteristics.characteristic: histological type
characteristics.text: No
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Case Set
characteristics.characteristic: study design
characteristics.text: Breast Neoplasms
characteristics.characteristic: study disease
characteristics.text: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing
characteristics.characteristic: study name
characteristics.text: Yes
characteristics.characteristic: subject is affected
characteristics.text: Sample_NORMAL_287
characteristics.characteristic: submitted sample id
characteristics.text: Subject_287
characteristics.characteristic: submitted subject id
characteristics.text: NCI_CALGB_40603
characteristics.characteristic: submitter handle
characteristics.text: Non-tumor DNA sample from blood of a human female participant in the dbGaP study "Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing"
characteristics.characteristic: title